Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography

Abstract

This study described the radiological features on echocardiography and MRI specific to cardiac amyloidosis confirmed on biopsy. Eleven cases of biopsy-proven cardiac amyloidosis were retrospectively reviewed in this study. All patients underwent biopsy, cardiac MRI and echocardiography. The main echocardiography and MRI findings were as follows: diffuse ventricular and septum wall thickening, atrial enlargement, pericardial effusion, restricted left ventricular (LV) systolic and diastolic function, characteristic granular sparkling of myocardium. MRI revealed a characteristic pattern of global subendocardial late enhancement, extending in varying degrees into the neighboring myocardium. The findings agreed with the infiltration distribution of amyloid protein. Typical abnormalities seen on echocardiography and MRI should have important diagnostic and prognostic value of cardiac amyloidosis. MRI should be considered in the diagnosis of cardiac amyloidosis if echocardiographic features are suspicious.

Keywords

amyloidosis / cardiomyopathy / cardiac MRI / echocardiography / diagnosis

References

[1] MengL., DingW.H., ShiL.B., et al.. The clinical features and outcomes of immunoglobulin light-chain amyloidosis with heart involvement. Chin J Cardiol (Chinese), 2007, 5(4): 340-343

[2] ZengY., ZhuW.L., FangL.G., et al.. The clinical characteristics and diagnosis of heart amyloidosis. Chin J Intern Med (Chinese), 2000, 39(2): 91-93

[3] vanden DriesenR.I., SlaughterR.E., StrugnellW.E., et al.. MR findings in cardiac amyloidosis. Am J Roentgenol, 2006, 186(6): 1682-1685

[4] DubreyS.W., ChaK., AndersonJ., et al.. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM, 1998, 91(2): 141-157

[5] MaceiraA.M., JoshiJ., PrasadS.K., et al.. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation, 2005, 111(2): 186-193

[6] FalkR.H.. Diagnosis and management of the cardiac amyloidoses. Circulation, 2005, 112(13): 2047-2060

[7] KwongR.Y., FalkR.H.. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation, 2005, 111(2): 122-124

[8] Siqueira-FilhoA.G., CunhaC.L., TajikA.J., et al.. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation, 1981, 63(1): 188-196

[9] AertsJ.G., TanK.Y., VeerhoekM., et al.. Pleural amyloidosis as a cause of excessive pleural effusions. Ned Tijdschr Geneeskd, 1999, 143(2): 104-106

[10] ChouT.R., TietjenP.A.. Pleural amyloidosis as a cause of pleural effusion. Chest, 2002, 122(Suppl4): S239-S240

[11] VogelsbergH., MahrholdtH., DeluigiC.C., et al.. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol, 2008, 51(10): 1022-1030

[12] PeruginiE., RapezziC., PivaT., et al.. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart, 2006, 92(3): 343-349

[13] SueyoshiE., SakamotoI., OkimotoT., et al.. Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrast enhanced MRI. Cardiovasc Intervent Radiol, 2006, 29(4): 710-712

[14] ChengA.S., BanningA.P., MitchellA.R., et al.. Cardiac changes in systemic amyloidosis: visualization by magnetic resonance imaging. Int J Cardiol, 2006, 113(1): 21-23

[15] ShahK.B., InoueY., MehraM.R.. Amyloidosis and the heart: a comprehensive review. Arch Intern Med, 2006, 166(17): 1805-1813

[16] SanchorawalaV.. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol, 2006, 1(6): 1331-1341

[17] ZhangL., LvQ., XieM.X., et al.. The diagnostic value of echocardiography in cardiac amloidsis. Chin J Ultrasonogr (Chinese), 2009, 18(1): 11-13

[18] RahmanJ.E., HelouE.F., Gelzer-BellR., et al.. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol, 2004, 43(3): 410-415

[19] FalkR.H., PlehnJ.F., DeeringT., et al.. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol, 1987, 59(5): 418-422

[20] KristenA.V., PerzJ.B., SchonlandS.O., et al.. Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail, 2007, 9(6–7): 617-624

[21] TeiC., DujardinK.S., HodgeD.O., et al.. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol, 1996, 28(3): 658-664

[22] MurtaghB., HammillS.C., GertzM.A., et al.. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol, 2005, 95(4): 535-537

[23] RahmanJ.E., HelouE.F., Gelzer-BellR., et al.. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol, 2004, 43(3): 410-415

[24] HongoM., YamamotoH., KohdaT., et al.. Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings. Am J Cardiol, 2000, 85(7): 849-853

[25] SongW., YanH.Z., WangY., et al.. Radiographic findings of thorax in primary amyloidosis (analysis of 9 cases). Chin J Radiol (Chinese), 2000, 34(3): 196-198